On the evening of March 17, CMS released its performance for 2024, achieving a total revenue of 7.469 billion yuan, which is a year-on-year decrease of 6.8%. The company realized a net income of 1.613 billion yuan for the year, and the normalized net income after excluding related asset impairment losses is 1.714 billion yuan. It is reported that the performance decline is mainly influenced by the implementation of national procurement. The revenue from three unselected original research drugs decreased by 28.8% year-on-year to 2.691 billion yuan in 2024. This impact is expected to be absorbed by 2025. For other core products except for these three, the majority are exclusive and innovative products. The revenue from exclusive and innovative products in 2024 is 4.551 billion yuan, an increase of 4.1% year-on-year, making up 52.8% of the total revenue.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
Starting at 0.199 million yuan, the price of full-size humanoid robots in China has broken the ice! The Siasun Robot&Automation Dobot Atom is available for pre-sale.
Lei Jun: The cumulative delivery volume of Xiaomi Autos has reached 0.2 million units.
Died at the age of 97! Lee Shau Kee, the founder of Henderson Land Development, passed away, recalling the legendary life of the 'Asian Stock God.'
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
康哲药业2024年营收74.69亿元 同比下降6.8%
CMS's revenue for 2024 is 7.469 billion yuan, a year-on-year decrease of 6.8%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 336
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report